Galderma Group AG
GALD
Company Profile
Business description
Galderma was formed in 1981 as a joint venture between Nestle and L’Oreal. It subsequently became a subsidiary of Nestle, called Nestle Skin Health, before being carved out and launched as a stand-alone company in 2019, acquired by a consortium led by Sweden-based EQT fund. The company went public in March 2024 and is listed on the SIX Swiss exchange. Galderma’s science-based portfolio spans multiple dermatology categories, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. It derives around 40% of net sales from the US and employs around 7,00 people.
Contact
Zahlerweg 10
Zug6300
CHET: +41 584558592
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
Stocks News & Analysis
stocks
Tesla: Shares down despite record deliveries
We think the positive third-quarter numbers will be largely offset by a weak fourth quarter.
stocks
ASX listed share dominates their industry
Shares are currently fairly valued with a Wide Moat rating.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,288.10 | 53.60 | 0.58% |
CAC 40 | 8,081.54 | 24.91 | 0.31% |
DAX 40 | 24,378.80 | 43.76 | -0.18% |
Dow JONES (US) | 46,758.28 | 238.56 | 0.51% |
FTSE 100 | 9,491.25 | 63.52 | 0.67% |
HKSE | 27,140.92 | 146.20 | -0.54% |
NASDAQ | 22,780.51 | 63.54 | -0.28% |
Nikkei 225 | 45,769.50 | 832.77 | 1.85% |
NZX 50 Index | 13,514.09 | 62.33 | 0.46% |
S&P 500 | 6,715.79 | 0.44 | 0.01% |
S&P/ASX 200 | 8,987.40 | 50.80 | 0.57% |
SSE Composite Index | 3,882.78 | 20.25 | 0.52% |